IMMIPRINT
LIVE

Serial Number

79219912

Owner

ProteinLogic Limited

Attorney

Lori S. Meddings

Filing Date

Sep 6, 2017

Add to watchlist:

No watchlists yet
View on USPTO

IMMIPRINT Trademark

Serial Number: 79219912 • Registration: 5766272

IMMIPRINT is a trademark filed by ProteinLogic Limited on September 6, 2017. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ProteinLogic Limited (3 trademarks)

Shakespeare House, 42 Newmarket Road
Cambridge CB58EP , GB

Entity Type: 03

Trademark Details

Filing Date

September 6, 2017

Registration Date

June 4, 2019

Published for Opposition

March 19, 2019

Goods & Services

Laboratory apparatus and equipment for use in the detection of soluble Cluster of Differentiation (CD) antigens, soluble immune system proteins, other soluble proteins in bodily fluids, and other soluble proteins in bodily fluids, namely, cytokines, all for research, diagnosis and monitoring of human and animal diseases and for the research and monitoring of treatments and therapies for human and animal diseases, namely, microplate readers, antibody bio-chips, flow cytometers, immuno detectors, microfluidic bio-chips, photometers, piezo electrical transducers, acoustic detectors and mass spectrometers; scientific apparatus and equipment for research purposes for use in the detection of soluble CD antigens, soluble immune system proteins, other soluble proteins in bodily fluids, and other soluble proteins in bodily fluids, namely, cytokines, all for use in the research of human and animal diseases and for the research of treatments and therapies for human and animal diseases, namely, microplate readers, antibody bio-chips, flow cytometers, immuno detectors, microfluidic bio-chips, photometers, piezo electrical transducers, acoustic detectors and mass spectrometers; measuring apparatus and instruments for use in connection with the research, diagnosis and monitoring of human and animal diseases and for the research and monitoring of treatments and therapies for human and animal diseases; computer software for receiving, processing, collating, analysing, transmitting, displaying and storing information and data, in connection with the research and diagnosis of human and animal diseases and for the monitoring of treatments and therapies for human and animal diseases; machine readable data carriers for use in connection with the research, diagnosis and monitoring of human and animal diseases and for the research and monitoring of treatments and therapies for human and animal diseases; data storage media for use with computers, namely, high speed computer storage sub-systems for storage and backup of electronic data either locally or via a telecommunications network, for receiving, processing, collating, analysing, transmitting, displaying and storing information and data, in connection with the research, diagnosis and monitoring of human and animal diseases and for the research and monitoring of treatments and therapies for human and animal diseases

Apparatus for clinical, medical and veterinary diagnosis, namely, reagent panels, microplate readers for blood and body fluid based diagnostic testing, antibody bio-chips for blood and body fluid based diagnostic testing, flow cytometers for blood and body fluid based diagnostic testing, immuno detectors for blood and body fluid based diagnostic testing, microfluidic biochips for blood and body fluid based diagnostic testing, photometers for blood and body fluid based diagnostic testing, piezo electrical transducers for blood and body fluid based diagnostic testing, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing; medical and veterinary testing apparatus for diagnosing human and animal diseases, in particular ones containing chemical and/or biochemical reagents, namely, reagent panels, microplate readers for blood and body fluid based diagnostic testing, antibody bio-chips for blood and body fluid based diagnostic testing, flow cytometers for blood and body fluid based diagnostic testing, immuno detectors for blood and body fluid based diagnostic testing, microfluidic bio-chips for blood and body fluid based diagnostic testing, photometers for blood and body fluid based diagnostic testing, piezo electrical transducers for blood and body fluid based diagnostic testing, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing; apparatus and instruments for medical and clinical analysis diagnosis for use in the detection of soluble CD antigens, soluble immune system proteins, other soluble proteins in bodily fluids, and other soluble proteins in bodily fluids, namely, cytokines, all for use in the diagnosis and monitoring of human and animal diseases and for the monitoring of treatments and therapies for human and animal diseases, namely, reagent panels, microplate readers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, antibody biochips for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, flow cytometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, immuno detectors for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring and predicting response to treatments and therapies, and patient stratification, microfluidic bio-chips for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring and predicting response to treatments and therapies, and patient stratification, photometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring and predicting response to treatments and therapies, and patient stratification, piezo electrical transducers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring and predicting response to treatments and therapies, and patient stratification, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring and predicting response to treatments and therapies, and patient stratification

Scientific research; bacteriological research; biochemical research and development; biological research; clinical research in the nature of providing medical and scientific research information in the field of biomarker signature discovery and immune system response based diagnostics and proteomic diagnostics; medical research, biomedical research services; chemical research and analysis services in the nature of providing medical and scientific research information in the field of biomarker signature discovery and immune system response based diagnostics and proteomic diagnostics; genetic research in the nature of providing medical and scientific research information in the field of biomarker signature discovery and immune system response based diagnostics and proteomic diagnostics; design services in the field of biomarker signature discovery and immune system response based diagnostics and proteomic diagnostics

Filing History

LIMITATION FROM THE IB EXAMINED AND ENTERED
Dec 29, 2022 LIME
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Dec 29, 2022 DENC
LIMITATION OF GOODS RECEIVED FROM IB
Sep 10, 2022 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 4, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 18, 2019 FICS
FINAL DISPOSITION PROCESSED
Sep 18, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 4, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 4, 2019 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 19, 2019 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 3, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 3, 2019 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 19, 2019 NPUB
PUBLISHED FOR OPPOSITION
Mar 19, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Mar 15, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 27, 2019 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 27, 2019 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 27, 2019 OP2R
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 14, 2019 PREV
EXPARTE APPEAL TERMINATED
Feb 13, 2019 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 13, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 13, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 13, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 13, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 13, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2019 CRFA
ASSIGNED TO LIE
Jan 29, 2019 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 24, 2019 ERFR
EX PARTE APPEAL-INSTITUTED
Jan 24, 2019 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 24, 2019 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jan 24, 2019 EXAF
FINAL REFUSAL MAILED
Jul 24, 2018 CNFR
FINAL REFUSAL WRITTEN
Jul 24, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 27, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 27, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 27, 2018 TROA
REFUSAL PROCESSED BY IB
Jan 19, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 28, 2017 RFCS
REFUSAL PROCESSED BY MPU
Dec 28, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 14, 2017 RFCR
NON-FINAL ACTION WRITTEN
Dec 13, 2017 CNRT
ASSIGNED TO EXAMINER
Dec 11, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 10, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 2, 2017 REPR